Delving into the latest JAHA review on immune checkpoint inhibitors and the heart has been illuminating 🔍❤️.
As immunotherapy transforms cancer care, we're learning that unleashed T-cells can also stir the silent storms within vulnerable plaques ⚡🩺.
This piece beautifully unpacks how ICIs may accelerate atherosclerosis, heighten ACS risk, and challenge our diagnostic instincts—especially when myocarditis and ischemia mimic one another 🎯🧬.
As we push the frontier of cancer survival, cardio-oncology must rise in parallel: better surveillance, smarter risk reduction, and deeper mechanistic insight 🚀📚.
A timely reminder that curing cancer and protecting the heart must go hand in hand 🤝❤️🔥.
